首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1375150

南美洲和中美洲结直肠癌诊断市场预测至 2028 年 - COVID-19 影响和区域分析 - 按模式和最终用户（医院、诊断实验室、癌症研究机构等）

South & Central America Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

出版日期: 2023年08月28日 | 出版商:

The Insight Partners | 英文 131 Pages | 订单完成后即时交付

价格

简介目录图表

2023年，南美洲和中美洲结直肠癌诊断市场价值为7.4913亿美元，预计到2028年将达到10.8786亿美元。预计2023年至2028年的复合年增长率为7.7%。

大肠镜检查中的人工智慧推动南美洲和中美洲结直肠癌诊断市场

胃肠病学中结直肠癌 (CRC) 的早期检测为患者提供了无疾病生存和整体生存的最佳机会。然而，大肠镜检查结果显示病变检测有显着差异。腺瘤检出率（ADR）是评估内视镜医师进行大肠直肠癌筛检的大肠镜检查品质的黄金标准。

利用人工智慧技术诊断和治疗多种癌症，尤其是大肠癌，目前正受到广泛关注。各种人工智慧支援系统可用于个人化和新颖的大肠直肠癌治疗策略。在内视镜检查中，人工智慧广泛涉及电脑视觉技术，允许电脑「看到」并解释视觉内容。透过机器学习过程和深度学习，可以训练人工智慧系统透过将黄金标准与合适的图像联繫起来来识别「正常」特征。使用电脑视觉进行病变检测将是人工智慧在胃肠病学中的首次应用。它将有助于提高结肠镜检查中发现和识别息肉的内视镜检查实践的品质。

儘管大肠镜检查中的人工智慧是一个广泛的新领域，但它可以潜在地提高内视镜检查和患者护理的品质。它还可以改变大肠镜检查的管理绩效和品质改进的过程，同时改善几个关键绩效指标。美敦力 (Medtronic) 在印度推出了人工智慧驱动的 GI Genius 大肠镜检查模组。这种依赖深度学习演算法和即时资料的变革性解决方案使医生能够透过在结肠镜检查过程中提供增强的可视化来检测和治疗大肠直肠癌。 GI Genius 等人工智慧应用可以改善 ADR，促进结直肠癌的早期检测、更好的病变临床管理以及组织的详细表征。因此，采用人工智慧进行大肠直肠癌成像测试可能会在未来几年为南美洲和中美洲结直肠癌诊断市场带来新趋势。

南美洲和中美洲大肠癌诊断市场概述

南美洲和中美洲大肠直肠癌诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。据巴西卫生部称，由于农作物使用杀虫剂，结肠癌病例显着增加。食用此类食物和水会导致结肠癌的发生。此外，老年人中结直肠癌的盛行率较高。根据 Globocan 2020资料，2020 年巴西新增约 55,102 例大肠直肠癌病例。此外，男性病例为 27,346 例，女性病例为 27,756 例。巴西各地，特别是私营部门，开展了有关大肠癌的宣传活动。巴西肠癌预防协会 (ABRAPRECI) 和大肠癌预防和筛检计画已经启动。宣传活动和筛检计画的成长增加了对大肠镜检查服务的需求。此外，2020年12月，法国诊断公司HalioDx与Diagnostics da America (DASA)签署协议，在巴西分销其Immunoscore结肠癌风险评估测试。免疫评分透过测量肿瘤部位的宿主免疫反应来帮助预测早期结肠癌復发的风险，这有助于规划治疗策略。根据协议条款，位于巴西圣保罗的 DASA 拥有该测试的独家经销权，透过 40 个实验室网路提供该测试。由于上述因素，巴西南美洲和中美洲大肠直肠癌诊断市场在预测期内可能会出现利润丰厚的机会。

南美洲和中美洲大肠癌诊断市场收入及 2028 年预测（百万美元）

南美洲和中美洲大肠癌诊断市场细分

南美洲和中美洲大肠直肠癌诊断市场分为模式、最终用户和国家。

根据模式，南美洲和中美洲大肠直肠癌诊断市场分为影像学检查和粪便测试。 2023年，影像测试领域在南美洲和中美洲结直肠癌诊断市场中占据更大份额。影像测试市场进一步细分为大肠镜检查、CT结肠造影、柔性乙状结肠镜检查、胶囊内视镜检查等。基于粪便的检测市场细分为粪便免疫化学测试（fit）、基于癒创木脂的粪便潜血测试（gfobt）和粪便DNA测试。

根据最终用户，南美洲和中美洲大肠直肠癌诊断市场分为医院、诊断实验室、癌症研究机构等。 2023年，医院细分市场在南美洲和中美洲结直肠癌诊断市场中占据最大份额。

根据国家/地区，南美洲和中美洲结直肠癌诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2023年，巴西占据南美洲和中美洲结直肠癌诊断市场的最大份额。

Medtronic Plc、Illumina Inc、F. Hoffmann-La Roche Ltd、Quest Diagnostics Inc、Siemens Healthineers AG、Bruker Corp.；和 Eiken Chemical Co., Ltd. 是南美洲和中美洲结直肠癌诊断市场的领先公司。

The early detection of colorectal cancer (CRC) in gastroenterology offers patients the best opportunity for disease-free and overall survival. However, colonoscopy results show significant variations in lesion detection. The adenoma detection rate (ADR) is the gold standard for evaluating the quality of colonoscopy performed by endoscopists for colorectal cancer screening.

The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to "see" and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize "normal" characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.

Although AI in colonoscopy is a new field with an extended scope, it can potentially improve the quality of endoscopic examinations and patient care. It can also transform the process of managing performance and quality betterment in colonoscopy, alongside improving several key performance measures. Medtronic has launched its AI-powered GI Genius module for colonoscopy in India. This transformative solution that leans on deep learning algorithms and real-time data empowers physicians to detect and treat colorectal cancer by offering enhanced visualization during colonoscopy. AI applications such as the GI Genius can lead to an improved ADR, facilitating the earlier detection of colorectal cancer, better clinical management of lesions, and detailed characterization of tissues. Thus, the adoption of AI for colorectal cancer imaging tests is likely to bring new trends in the South & Central America colorectal cancer diagnostics market in the coming years.

South & Central America Colorectal Cancer Diagnostics Market Overview

The South & Central America colorectal cancer diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. According to the Brazilian Ministry of Health, cases of colon cancer have increased significantly due to the pesticides applied to the crops. Consumption of such food and water can lead to the development of colon cancer. In addition, the prevalence of colorectal cancer is higher among older adults. In 2020, around 55,102 new colorectal cancer cases were recorded in Brazil, as per Globocan 2020 data. In addition, 27,346 cases were reported in males and 27,756 in females. Awareness campaigns regarding colorectal cancer have grown across Brazil, especially from the private sector. The Brazilian Association of Intestinal Cancer Prevention (ABRAPRECI) and the Colorectal Cancer Prevention and Screening Program have been initiated. The growth in awareness campaigns and screening programs has increased the demand for colonoscopy services. In addition, in December 2020, a French diagnostic firm HalioDx signed an agreement with Diagnosticos da America (DASA) to distribute its Immunoscore colon cancer risk-assessment test in Brazil. Immunoscore assists in predicting the risk of relapse in early-stage colon cancer by measuring host immune responses at tumor sites, which helps plan treatment strategies. Under the agreement terms, in Brazil, Sao Paulo-based DASA has exclusive distribution rights to the test, offering it through 40 laboratory networks. Owing to the above-mentioned factors, the South & Central America colorectal cancer diagnostics market in Brazil is likely to witness lucrative opportunities during the forecast period.

South & Central America Colorectal Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Colorectal Cancer Diagnostics Market Segmentation

The South & Central America colorectal cancer diagnostics market is segmented into modality, end user, and country.

Based on modality, the South & Central America colorectal cancer diagnostics market is bifurcated into imaging tests and stool-based tests. In 2023, the imaging tests segment held a larger share of the South & Central America colorectal cancer diagnostics market. The market for the imaging tests segment is further segmented into colonoscopy, ct colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gfobt), and stool DNA test.

Based on end user, the South & Central America colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2023, the hospitals segment held the largest share of the South & Central America colorectal cancer diagnostics market.

Based on country, the South & Central America colorectal cancer diagnostics market is segmented into Brazil, Argentina, and Rest of South & Central America. In 2023, Brazil accounted for the largest share of the South & Central America colorectal cancer diagnostics market.

Medtronic Plc, Illumina Inc, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, Bruker Corp.; and Eiken Chemical Co., Ltd. are the leading companies operating in the South & Central America colorectal cancer diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America colorectal cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America colorectal cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the colorectal cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Colorectal Cancer Diagnostics Market - by Modality
- 1.3.2 South & Central America Colorectal Cancer Diagnostics Market - by End User
- 1.3.3 South & Central America Colorectal Cancer Diagnostics Market - by Country

2. South & Central America Colorectal Cancer Diagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Colorectal Cancer Diagnostics Market - Market Landscape

4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert's Opinion

5. South & Central America Colorectal Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Colorectal Cancer
- 5.1.2 Launches of New Products
5.2 Key Restraints
- 5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Future Trends
- 5.3.1 Artificial Intelligence in Colonoscopy
5.4 Impact Analysis

6. Colorectal Cancer Diagnostics Market - South & Central America Analysis

6.1 South & Central America Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis

7. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - by Modality

7.1 Overview
7.2 South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
- 7.3.1 Overview
- 7.3.2 Stool Based Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Faecal Immunochemical Test (FIT)
  - 7.3.3.1 Overview
  - 7.3.3.2 Faecal Immunochemical Test (FIT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
  - 7.3.4.1 Overview
  - 7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Stool DNA Test
  - 7.3.5.1 Overview
  - 7.3.5.2 Stool DNA Test: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
- 7.4.1 Overview
- 7.4.2 Imaging Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Colonoscopy
  - 7.4.3.1 Overview
  - 7.4.3.2 Colonoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 CT Colonography
  - 7.4.4.1 Overview
  - 7.4.4.2 CT Colonography: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Flexible Sigmoidoscopy
  - 7.4.5.1 Overview
  - 7.4.5.2 Flexible Sigmoidoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.6 Capsule Endoscopy
  - 7.4.6.1 Overview
  - 7.4.6.2 Capsule Endoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.7 Others
  - 7.4.7.1 Overview
  - 7.4.7.2 Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - by End User

8.1 Overview
8.2 South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
- 8.4.1 Overview
- 8.4.2 Diagnostic Laboratories: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
- 8.5.1 Overview
- 8.5.2 Cancer Research Institutes: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 - Country Analysis

9.1 Overview
- 9.1.1 South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
  - 9.1.1.1 Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.1.3 Brazil: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
    - 9.1.1.1.3.1 Brazil: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.1.3.2 Brazil: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.1.4 Brazil: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)
  - 9.1.1.2 Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.2.3 Argentina: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
    - 9.1.1.2.3.1 Argentina: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.2.3.2 Argentina: Colorectal Cancer Diagnostics Market, For Stool-Based Tests, 2020-2028 (US$ Million)
    - 9.1.1.2.4 Argentina: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)
  - 9.1.1.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020-2028 (US$ Million)
    - 9.1.1.3.3.1 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.3.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020-2028 (US$ Million)
    - 9.1.1.3.4 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020-2028 (US$ Million)

10. South & Central America Colorectal Cancer Diagnostics Market-Industry Landscape

10.1 Overview
10.2 Inorganic Growth Strategies
- 10.2.1 Overview
10.3 Organic Growth Strategies
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Illumina Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Quest Diagnostics Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Siemens Healthineers AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Bruker Corp
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Eiken Chemical Co., Ltd.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. South & Central America Colorectal Cancer Diagnostics Market -Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of South & Central America Colorectal Cancer Diagnostics Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South & Central America Colorectal Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Recent Inorganic Growth Strategies in the South & Central America colorectal cancer diagnostics market
Table 15. Recent Organic Growth Strategies in the South & Central America colorectal cancer diagnostics market
Table 16. Glossary of Terms

List Of Figures

Figure 1. South & Central America Colorectal Cancer Diagnostics Market Segmentation
Figure 2. South & Central America Colorectal Cancer Diagnostics Market, by Country
Figure 3. South & Central America Colorectal Cancer Diagnostics Market Overview
Figure 4. Imaging Tests Segment Held Largest Share of Modality Segment in South & Central America Colorectal Cancer Diagnostics Market
Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
Figure 6. South and Central America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. South & Central America Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. South & Central America Colorectal Cancer Diagnostics Market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 11. Stool Based Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Faecal Immunochemical Test (FIT): South & Central Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Guaiac-based Faecal Occult Blood Test (gFOBT): South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Stool DNA Test: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Imaging Tests: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Colonoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. CT Colonography: South & Central American Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Flexible Sigmoidoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Capsule Endoscopy: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. South & Central America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
Figure 22. Hospitals: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Diagnostic Laboratories: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cancer Research Institutes: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: South & Central America Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. South & Central America: Colorectal Cancer Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
Figure 28. Brazil: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Argentina: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of South & Central America: Colorectal Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

02-2729-4219

+886-2-2729-4219

License/价格

南美洲和中美洲结直肠癌诊断市场预测至 2028 年 - COVID-19 影响和区域分析 - 按模式和最终用户（医院、诊断实验室、癌症研究机构等）

South & Central America Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

目录

第 1 章：简介

第 2 章：南美洲和中美洲大肠直肠癌诊断市场 - 要点

第 3 章：研究方法

第 4 章：南美洲和中美洲大肠直肠癌诊断市场 - 市场模式

第 5 章：南美洲和中美洲大肠直肠癌诊断市场 - 主要市场动态

第 6 章：大肠直肠癌诊断市场 - 南美洲和中美洲分析

第 7 章：南美洲和中美洲结直肠癌诊断市场 - 收入和 2028 年预测 - 按方式

第 8 章：南美洲和中美洲结直肠癌诊断市场 - 收入和 2028 年预测 - 按最终用户

第 9 章：南美洲和中美洲结直肠癌诊断市场 - 2028 年收入和预测 - 国家分析

第 10 章：南美洲和中美洲大肠直肠癌诊断市场-产业格局

第 11 章：公司简介

第 12 章：附录